CAS 722543-31-9 appears in our catalog under these names: 5-[[7-[3-[ethyl[2-(phosphonooxy)ethyl]amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-3-acetamide, 95%, Barasertib, AZD1152, Barasertib/ 99.63% (existing batch purity), AZD 1152. Offered by: Combi-blocks, TRC, GLPBio, TargetMol, Biosynth. Available pack sizes: 100mg, 500mg, 250mg, 10mg, 400mg, 5mg, 10mM (in 1ml dmso), 50mg.
AZT-1152 is a dihydrogen phosphate prodrug of a pyrazoloquinazoline aurora kinase inhibitor AZD1152-hydroxyquinazoline pyrazol anilide(HQPA) and is converted rapidly to the active AZD1152-HQPA in plasma. It has a role as an antineoplastic agent, a prodrug and an Aurora kinase inhibitor. It is an anilide, a secondary carboxamide, a monoalkyl phosphate, a member of pyrazoles, a member of quinazolines, a secondary amino compound, a tertiary amino compound and a member of monofluorobenzenes. It is functionally related to an AZD-1152.
Source: ChEBI
| Molecular formula | C26H31FN7O6P |
|---|---|
| Molecular weight | 587.5 g/mol |
| IUPAC name | 2-[ethyl-[3-[4-[[5-[2-(3-fluoroanilino)-2-oxoethyl]-1H-pyrazol-3-yl]amino]quinazolin-7-yl]oxypropyl]amino]ethyl dihydrogen phosphate |
| InChIKey | GBJVVSCPOBPEIT-UHFFFAOYSA-N |
| SMILES | CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCOP(=O)(O)O |
Computed by PubChem (NCBI)